Literature DB >> 27350325

Cunninghamella bertholletiae Infection in a HLA-Haploidentical Hematopoietic Stem Cell Transplant Recipient with Graft Failure: Case Report and Review of the Literature.

Chao Luo1,2, Jiasheng Wang1, Yongxian Hu1, Yi Luo1, Yamin Tan1, Aiyun Jin1, Bin Wei2, Huixian Hu2, He Huang3.   

Abstract

Cunninghamella bertholletiae as a rare cause of mucormycosis has been described almost exclusively in immunosuppressed patients such as hematopoietic stem cell transplant (HSCT) recipients. The infection is associated with high rates of mortality despite aggressive treatment. We describe a 40-year-old male with HLA-haploidentical HSCT developed fungal pneumonitis caused by C. bertholletiae complicated by graft failure and prolonged neutropenia. The patient died 102 days after HSCT despite early use of posaconazole and amphotericin B, which are believed to be the two most effective antifungal antibiotics against C. bertholletiae. The case highlights extreme unfavorable outcome in C. bertholletiae infection and neutropenia as a major risk factor.

Entities:  

Keywords:  Cunninghamella; Fungal pneumonia; Mucormycosis; Stem cell transplantation

Mesh:

Substances:

Year:  2016        PMID: 27350325     DOI: 10.1007/s11046-016-0030-7

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  20 in total

Review 1.  Cunninghamella infection post bone marrow transplant: case report and review of the literature.

Authors:  L Darrisaw; G Hanson; D H Vesole; S C Kehl
Journal:  Bone Marrow Transplant       Date:  2000-06       Impact factor: 5.483

Review 2.  The changing face of invasive fungal infections in hematopoietic cell transplant recipients.

Authors:  John R Wingard
Journal:  Curr Opin Oncol       Date:  2005-03       Impact factor: 3.645

Review 3.  Emergence of Cunninghamella as a pathogenic invasive mold infection in allogeneic transplant recipients.

Authors:  Lynne Strasfeld; Luis Espinosa-Aguilar; James L Gajewski; Peter Stenzel; Agustin Pimentel; Elana Mater; Richard T Maziarz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-07-10

Review 4.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.

Authors:  Dimitrios P Kontoyiannis; Michail S Lionakis; Russell E Lewis; Georgios Chamilos; Mimi Healy; Cheryl Perego; Amar Safdar; Hagop Kantarjian; Richard Champlin; Thomas J Walsh; Issam I Raad
Journal:  J Infect Dis       Date:  2005-03-16       Impact factor: 5.226

6.  Cunninghamella bertholletiae pneumonia showing a reversed halo sign on chest computed tomography scan following cord blood transplantation.

Authors:  Muneyoshi Kimura; Hideki Araoka; Naoyuki Uchida; Hideaki Ohno; Yoshitsugu Miyazaki; Takeshi Fujii; Aya Nishida; Koji Izutsu; Atsushi Wake; Shuichi Taniguchi; Akiko Yoneyama
Journal:  Med Mycol       Date:  2011-11-22       Impact factor: 4.076

7.  Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature.

Authors:  Jorge Garbino; Catherine Myers; Juan Ambrosioni; Fabienne Gumy-Pause
Journal:  J Pediatr Hematol Oncol       Date:  2010-03       Impact factor: 1.289

8.  Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism.

Authors:  Vidmantas Petraitis; Ruta Petraitiene; Charalampos Antachopoulos; Johanna E Hughes; Margaret P Cotton; Miki Kasai; Susan Harrington; Maria N Gamaletsou; John D Bacher; Dimitrios P Kontoyiannis; Emmanuel Roilides; Thomas J Walsh
Journal:  Med Mycol       Date:  2012-06-11       Impact factor: 4.076

9.  In vitro susceptibilities of zygomycetes to conventional and new antifungals.

Authors:  Eric Dannaoui; Joseph Meletiadis; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790

10.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

View more
  1 in total

1.  The Curious Case of "Case Report" of Infections Caused by Human and Animal Fungal Pathogens: An Educational Tool, an Online Archive, or a Format in Need of Retooling.

Authors:  Jean-Philippe Bouchara; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2018-12       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.